ALC:NYSE
Alcon AG
76,55 $
arrow_downward
-0,98%(-0,76) 1 d.
74,27 $
arrow_downward
-2,98% (-2,28)todayPirmstirdzniecības
Slēgts: 5. nov., 16:00:04 GMT-5 · USD
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: ALC…
Atvērt
77,17 $
Augsta
77,82 $
Zema
76,18 $
Tirgus kapitalizācija
30,21 mljrd.
Vid. apjoms
1,80 milj.
Apjoms
3,62 tūkst.
Augstākā 52 ned.
87,64 $
Zemākā 52 ned.
61,84 $
Beta
0,87
Apgrozībā esošās akcijas
483,40 milj.
Darbinieku skaits
25 tūkst.
Atvērt
77,17 $
Augsta
77,82 $
Zema
76,18 $
Tirgus kapitalizācija
30,21 mljrd.
Vid. apjoms
1,80 milj.
Apjoms
3,62 tūkst.
Augstākā 52 ned.
87,64 $
Zemākā 52 ned.
61,84 $
Beta
0,87
Apgrozībā esošās akcijas
483,40 milj.
Darbinieku skaits
25 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
Zacks
·
pirms 21 stundas
Countdown to Alcon (ALC) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Zacks
·
pirms 23 stundām
Alcon (ALC) Surges 6.8%: Is This an Indication of Further Gains?
Yahoo Finance
·
pirms 1 dienas
Alcon Inc. (ALC) Is Positioned to Benefit From Long-Term Healthcare Demand: Here’s the Investment Case
Profils
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Par “Alcon AG”
ĢenerāldirektorsDavid J. Endicott
Darbinieki25 tūkst.
Dibināšanas datums1945
Galvenais birojsŽenēva, Ženēva, Šveice
SektorsHealth Care
Industry-
Tīmekļa vietnealcon.com